Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
CordenPharma
CordenPharma
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
Design & Build
CordenPharma expands early clinical peptide manufacturing offering
CordenPharma is pleased to announce the commissioning of new GMP capacities at Frankfurt to manufacture early clinical phase peptide APIs for pharma and biotech customers
Manufacturing
CordenPharma launches lipid nanoparticle starter kits
The kits will aid in loss mitigation of high-value payloads during the gene editing journey to market
Research & Development
CordenPharma and pHLIP to develop pHLIP LNP targeted delivery platform for RNA and gene therapies
Manufacturing
CPHI Barcelona Snapshot: CordenPharma
At CPHI Barcelona, Dr Kevin Robinson talked to Dr Michael Quirmbach, CEO and President of CordenPharma, about the company’s recent activities and what lies ahead
Manufacturing
CordenPharma increases peptide production capacity
Following the signature of a multi-year large scale peptide manufacturing agreement earlier this year, CordenPharma has announced the inauguration of increased commercial peptide production capacity with newly-upgraded facilities
Research & Development
CordenPharma creates Technology and Science Advisory Board to drive company forward
The board is comprised of eight renowned experts from academia and industry, who will provide strategic guidance and scientific expertise to drive forward
Subscribe now